H. Tada

发表

Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 expression in rat kidneys with ischemia/reperfusion injury.

T. Habuchi, S. Satoh, M. Saito*, 2005, Archives of histology and cytology.

Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes.

N. Yasui-Furukori, M. Miura, Toshio Suzuki, 2005, Chirality.

Stereoselective metabolism of rabeprazole-thioether to rabeprazole by human liver microsomes

T. Habuchi, M. Miura, S. Satoh, 2006, European Journal of Clinical Pharmacology.

Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction.

M. Miura, Toshio Suzuki, H. Tada, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.

T. Habuchi, N. Tsuchiya, S. Satoh, 2005, Transplantation proceedings.

Circadian Pharmacokinetics of Mycophenolic Acid and Implication of Genetic Polymorphisms for Early Clinical Events in Renal Transplant Recipients

T. Habuchi, N. Tsuchiya, Zhenhua Li, 2006, Transplantation.

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole

N. Yasui-Furukori, M. Miura, H. Kagaya, 2006, Xenobiotica; the fate of foreign compounds in biological systems.

Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.

N. Yasui-Furukori, M. Miura, Toshio Suzuki, 2005, British journal of clinical pharmacology.

Influence of CYP3A5 and MDR1 (ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients

T. Habuchi, N. Tsuchiya, Zhenhua Li, 2004, Transplantation.

Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy

H. Tada, K. Togami, Yukimune Kanehira, 2015, Biopharmaceutics & drug disposition.

[Meta-analysis-based examination regarding the efficacy of angiotensin II receptor blockers and calcium channel blockers in borderline diabetes and diabetes patients].

M. Miura, H. Tada, K. Mohri, 2011, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Lipids behavior and adverse effects for oral antidiabetic agents in patients with Type 2 diabetes treated with sulfonylureas alone based on systematic review.

M. Miura, Toshio Suzuki, H. Tada, 2007, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Tumor distribution and anti-tumor effect of doxorubicin following intrapulmonary administration to mice with metastatic lung tumor

H. Tada, S. Chono, K. Togami, 2016 .

Evaluation of various tissue-clearing techniques for the three-dimensional visualization of liposome distribution in mouse lungs at the alveolar scale.

H. Tada, S. Chono, K. Togami, 2019, International journal of pharmaceutics.

Multiscale live imaging using Förster Resonance Energy Transfer (FRET) for evaluating the biological behavior of nanoparticles as drug carriers.

H. Tada, S. Chono, K. Togami, 2020, Journal of pharmaceutical sciences.

The Clinical Effects of Flecainide on Ventricular Premature Contractions and Its Pharmacokinetics

M. Miura, Toshio Suzuki, H. Tada, 1990 .

Role of diltiazem on tacrolimus pharmacokinetics in tacrolimus-induced nephrotoxic rats.

H. Tada, K. Ito, S. Yanagiwara, 1999, Pharmacology & toxicology.

Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients.

T. Habuchi, N. Tsuchiya, Kazuyuki Inoue, 2008, British journal of clinical pharmacology.

Syntheses, physical properties and X-ray structures of benzocycloheptene-1,4,7-trione and its 6-phenylthio- and 6,8-bis(phenylthio) derivatives. Novel A, A–D and D–A–D molecular units aiming at organic conductors

H. Tada, K. Furuichi, M. Hashimoto, 1993 .

Phage Display Cloning and Characterization of Monoclonal Antibody Genes and Recombinant Fab Fragment against the CD98 Oncoprotein

T. Masuko, Kazuyuki Inoue, K. Itoh, 2001, Japanese journal of cancer research : Gann.

Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for idiopathic pulmonary fibrosis.

H. Tada, K. Togami, Yukimune Kanehira, 2013, Biological & pharmaceutical bulletin.

General and facile method for determination of configuration of steroid-17-yl methyl glycolates at C-20 based on kinetic examination

Toshio Suzuki, H. Tada, 1998 .

Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib-hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis.

H. Tada, S. Chono, K. Togami, 2022, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Alteration in Intrapulmonary Pharmacokinetics of Aerosolized Model Compounds Due to Disruption of the Alveolar Epithelial Barriers Following Bleomycin-Induced Pulmonary Fibrosis in Rats.

H. Tada, S. Chono, K. Togami, 2016, Journal of pharmaceutical sciences.

Synthesis and Physical Properties of 6,8-Bis(phenylthio)-7H-benzocycloheptene-1,4,7-trione. A Novel D-s-A-s-D Molecular Unit Directed toward Organic Conductors

H. Tada, K. Furuichi, M. Hashimoto, 1991 .

Prolonged distribution of aerosolized PEGylated liposomes in the lungs of mice with bleomycin-induced pulmonary fibrosis

H. Tada, S. Chono, K. Togami, 2020, Drug development and industrial pharmacy.

Development of visualization and analysis methods for evaluating intratumoral nanoparticle kinetics for tumor-targeted drug delivery using Förster resonance energy transfer in vivo live imaging and tissue clearing techniques.

H. Tada, S. Chono, K. Togami, 2022, Journal of pharmaceutical and biomedical analysis.

Effects of thymic hormone on reactive oxygen species-scavengers and renal function in tacrolimus-induced nephrotoxicity.

A. Awaya, Kazuyuki Inoue, K. Itoh, 2002, Life sciences.

Examination on biological activities and fates of new steroids, steroid-17-yl methyl glycolate derivatives.

H. Tada, T. Suzuki, Y. Tojima, 1999, The Tohoku journal of experimental medicine.

Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes.

N. Yasui-Furukori, M. Miura, H. Kagaya, 2006, British journal of clinical pharmacology.

PHARMACOKINETICS A ND D ISPOSITION

N. Yasui-Furukori, M. Miura, Toshio Suzuki, 2002 .

Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients

T. Habuchi, Kazuyuki Inoue, M. Miura, 2007, European Journal of Clinical Pharmacology.

Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes

N. Yasui-Furukori, M. Miura, H. Tada, 2004, European Journal of Clinical Pharmacology.

Application of sweet potato fiber to skin wound in rat.

H. Tada, T. Suzuki, E. Sato, 1996, Biological & pharmaceutical bulletin.

Chronopharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Occurrence of Acute Rejection

Tetsuro Kato, Toshio Suzuki, H. Tada, 2003, Journal of clinical pharmacology.

General method for the preparation of α-methylene-γ-butyrolactones from (R)- and (S)-1,2-isopropylideneglyceraldehydes

Toshio Suzuki, H. Tada, T. Kametani, 1986 .

Enantioselective uptake of fexofenadine by Caco‐2 cells as model intestinal epithelial cells

H. Tada, K. Morimoto, S. Chono, 2013, The Journal of pharmacy and pharmacology.

Clinical and Genetic Risk Factors for Posttransplant Diabetes Mellitus in Adult Renal Transplant Recipients Treated with Tacrolimus

T. Habuchi, N. Tsuchiya, S. Satoh, 2005, Transplantation.

Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction.

T. Habuchi, M. Miura, S. Satoh, 2006, Journal of pharmaceutical and biomedical analysis.

INFLUENCE OF FOOD ON BIOAVAILABILITY FROM TWO CONTROLLED‐RELEASE GRANULES OF THEOPHYLLINE

H. Tada, Y. Ohmiya, T. Suzuki, 1989, Journal of clinical pharmacy and therapeutics.

Quantification and 24-hour monitoring of mycophenolic acid by high-performance liquid chromatography in Japanese renal transplant recipients.

T. Habuchi, M. Miura, S. Satoh, 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

The Effect of Dexmedetomidine on Oral Mucosal Blood Flow and the Absorption of Lidocaine.

H. Tada, S. Yamazaki, K. Togami, 2018, Anesthesia progress.

Dexmedetomidine decreases the oral mucosal blood flow.

S. Ganzberg, H. Tada, S. Yamazaki, 2013, The British journal of oral & maxillofacial surgery.

Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-β1 in A549, NCI-H441, and Calu-3 cells: Development of an in vitro model of respiratory epithelial cells in idiopathic pulmonary fibrosis.

H. Tada, S. Chono, K. Togami, 2017, Journal of pharmacological and toxicological methods.

Recombinant human monoclonal Fab fragments against rotavirus from phage display combinatorial libraries.

T. Suzuki, K. Itoh, K. Inoue, 1999, Journal of biochemistry.

Facile and rapid high‐performance liquid chromatography method for simultaneous determination of allopurinol and oxypurinol in human serum

T. Suzuki, K. Itoh, H. Tada, 2003, Journal of clinical pharmacy and therapeutics.

Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.

T. Habuchi, N. Tsuchiya, Kazunari Sato, 2005, Transplantation proceedings.

Chrono and clinical pharmacokinetic study of tacrolimus in continuous intravenous administration

T. Habuchi, N. Tsuchiya, Kazunari Sato, 2001, International journal of urology : official journal of the Japanese Urological Association.

Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.

T. Suzuki, K. Itoh, K. Inoue, 2001, The Tohoku journal of experimental medicine.

Three-Dimensional Imaging of Pulmonary Fibrotic Foci at the Alveolar Scale Using Tissue-Clearing Treatment with Staining Techniques of Extracellular Matrix

H. Tada, S. Chono, K. Togami, 2020, Int. J. Biomed. Imaging.

Lidocaine concentration in mandibular bone after subperiosteal infiltration anesthesia decreases with elevation of periosteal flap and irrigation with saline.

H. Tada, S. Yamazaki, H. Kawaai, 2014, Anesthesia progress.

Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients

T. Habuchi, M. Miura, S. Satoh, 2007, Biopharmaceutics & drug disposition.

Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers

T. Habuchi, M. Miura, S. Satoh, 2005, Xenobiotica; the fate of foreign compounds in biological systems.

Influence of Cytochrome P450 (CYP) 3A5 Polymorphisms on the Pharmacokinetics of Lansoprazole Enantiomers in CYP2C19 Extensive Metaboliser Renal Transplant Recipients

T. Habuchi, M. Miura, S. Satoh, 2007, Clinical drug investigation.

Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus.

M Miura, S Satoh, H Tada, 2006, International journal of clinical pharmacology and therapeutics.

Polymerase chain reaction-single-strand conformation polymorphism based determination of two major genetic defects responsible for a phenotypic polymorphism of cytochrome P450 (CYP) 2C19 in the Japanese population.

T. Suzuki, K. Itoh, K. Inoue, 2000, Analytical biochemistry.

Molecular structural and functional characterization of tumor suppressive anti-ErbB-2 monoclonal antibody by phage display system.

T. Masuko, Y. Hashimoto, K. Itoh, 2003, Journal of biochemistry.

Intratumoral delivery and therapeutic efficacy of nanoparticle-encapsulated anti-tumor siRNA following intrapulmonary administration for potential treatment of lung cancer

H. Tada, S. Chono, K. Togami, 2019, Pharmaceutical development and technology.

Evaluation of tissue-clearing techniques for intraorgan imaging of distribution of polymeric nanoparticles as drug carriers

H. Tada, S. Chono, K. Togami, 2020, Drug development and industrial pharmacy.

Efficient delivery to human lung fibroblasts (WI-38) of pirfenidone incorporated into liposomes modified with truncated basic fibroblast growth factor and its inhibitory effect on collagen synthesis in idiopathic pulmonary fibrosis.

H. Tada, S. Chono, K. Miyakoshi, 2015, Biological & pharmaceutical bulletin.

Enhancement of electron affinity of benzocycloheptene-1,4,7-trione by substitution

H. Tada, K. Furuichi, M. Hashimoto, 1992 .

Immunoliposome-mediated gene transfer into cultured myotubes.

H. Tada, Y. Sawaishi, T. Suzuki, 2000, The Tohoku journal of experimental medicine.

Tissue-Clearing Techniques Enable Three-Dimensional Visualization of Aerosolized Model Compound and Lung Structure at the Alveolar Scale.

H. Tada, S. Chono, K. Togami, 2018, Biological & pharmaceutical bulletin.

Predictive factors of a response to interferon therapy in chronic hepatitis C.

H. Nomura, S. Kashiwagi, H. Tada, 1996, Journal of clinical gastroenterology.

Evaluation of the Dissolution Characteristics and the Performance of Sustained-release Preparations in a Once Daily Administration.

Toshio Suzuki, H. Tada, K. Ito, 1997 .

H. Tada, S. Chono, K. Togami, 2017, Journal of pharmacological and toxicological methods.

H. Tada, S. Chono, K. Miyakoshi, 2015, Biological & pharmaceutical bulletin.